微芯生物：西达本胺片被纳入2025年国家医保目录

Core Points - Microchip Biotech (688321) announced on December 7 that its product, Sidabenamine Tablets (Aipusha), has been included in the National Medical Insurance Directory under regular Category B management [1] Group 1 - The inclusion of Sidabenamine Tablets in the National Medical Insurance Directory is a significant development for the company [1] - This decision is based on the notice issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security regarding the updated drug directories for basic medical insurance and commercial health insurance [1]